Clinical Trials Browser

Phase 4 × Carcinoma, Non-Small-Cell Lung × Cisplatin × Clear all

NCT06357598 2024-04-10

PILOT

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05312840 2022-04-06

Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03092986 2019-03-08

Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT02316327 2016-10-05

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02000531 2016-01-13

Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population

Phase 4 Completed

45 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT02513355 2015-08-04

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02497118 2015-07-14

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT00686322 2011-09-15

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms